9-99865020-A-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_006981.4(NR4A3):​c.*1153A>G variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.465 in 201,244 control chromosomes in the GnomAD database, including 23,138 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 16696 hom., cov: 31)
Exomes 𝑓: 0.50 ( 6442 hom. )

Consequence

NR4A3
NM_006981.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 5.18

Publications

11 publications found
Variant links:
Genes affected
NR4A3 (HGNC:7982): (nuclear receptor subfamily 4 group A member 3) This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. The encoded protein may act as a transcriptional activator. The protein can efficiently bind the NGFI-B Response Element (NBRE). Three different versions of extraskeletal myxoid chondrosarcomas (EMCs) are the result of reciprocal translocations between this gene and other genes. The translocation breakpoints are associated with Nuclear Receptor Subfamily 4, Group A, Member 3 (on chromosome 9) and either Ewing Sarcome Breakpoint Region 1 (on chromosome 22), RNA Polymerase II, TATA Box-Binding Protein-Associated Factor, 68-KD (on chromosome 17), or Transcription factor 12 (on chromosome 15). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
NAMA (HGNC:42408): (non-protein coding RNA, associated with MAP kinase pathway and growth arrest)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.554 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006981.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NR4A3
NM_006981.4
MANE Select
c.*1153A>G
3_prime_UTR
Exon 8 of 8NP_008912.2
NR4A3
NM_173200.3
c.*1153A>G
3_prime_UTR
Exon 9 of 9NP_775292.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NR4A3
ENST00000395097.7
TSL:1 MANE Select
c.*1153A>G
3_prime_UTR
Exon 8 of 8ENSP00000378531.2
NR4A3
ENST00000330847.1
TSL:5
c.*1153A>G
3_prime_UTR
Exon 7 of 7ENSP00000333122.1
NR4A3
ENST00000618101.4
TSL:5
c.*1153A>G
3_prime_UTR
Exon 9 of 9ENSP00000482027.1

Frequencies

GnomAD3 genomes
AF:
0.453
AC:
68712
AN:
151844
Hom.:
16689
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.304
Gnomad AMI
AF:
0.612
Gnomad AMR
AF:
0.425
Gnomad ASJ
AF:
0.539
Gnomad EAS
AF:
0.361
Gnomad SAS
AF:
0.277
Gnomad FIN
AF:
0.465
Gnomad MID
AF:
0.554
Gnomad NFE
AF:
0.559
Gnomad OTH
AF:
0.490
GnomAD4 exome
AF:
0.503
AC:
24793
AN:
49282
Hom.:
6442
Cov.:
0
AF XY:
0.507
AC XY:
11573
AN XY:
22804
show subpopulations
African (AFR)
AF:
0.314
AC:
652
AN:
2078
American (AMR)
AF:
0.375
AC:
505
AN:
1348
Ashkenazi Jewish (ASJ)
AF:
0.531
AC:
1625
AN:
3058
East Asian (EAS)
AF:
0.377
AC:
3007
AN:
7984
South Asian (SAS)
AF:
0.278
AC:
119
AN:
428
European-Finnish (FIN)
AF:
0.480
AC:
220
AN:
458
Middle Eastern (MID)
AF:
0.534
AC:
156
AN:
292
European-Non Finnish (NFE)
AF:
0.557
AC:
16461
AN:
29570
Other (OTH)
AF:
0.504
AC:
2048
AN:
4066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
588
1175
1763
2350
2938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.452
AC:
68730
AN:
151962
Hom.:
16696
Cov.:
31
AF XY:
0.443
AC XY:
32884
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.303
AC:
12575
AN:
41474
American (AMR)
AF:
0.425
AC:
6482
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.539
AC:
1868
AN:
3468
East Asian (EAS)
AF:
0.361
AC:
1864
AN:
5170
South Asian (SAS)
AF:
0.280
AC:
1349
AN:
4820
European-Finnish (FIN)
AF:
0.465
AC:
4902
AN:
10532
Middle Eastern (MID)
AF:
0.548
AC:
161
AN:
294
European-Non Finnish (NFE)
AF:
0.559
AC:
37949
AN:
67932
Other (OTH)
AF:
0.485
AC:
1023
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1815
3629
5444
7258
9073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
628
1256
1884
2512
3140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.519
Hom.:
57961
Bravo
AF:
0.448
Asia WGS
AF:
0.323
AC:
1124
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
11
DANN
Benign
0.85
PhyloP100
5.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1131339; hg19: chr9-102627302; COSMIC: COSV58243713; API